Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic Comparison of Zegerid and Prevacid in Healthy Volunteers
NCT01005719Phase 3Completed
- Sponsor
- Bayer
- Start
- Sep 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Bayer. Started Sep 2009; status: completed.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01005719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01005719.